Limpar
2 resultados

Acesso aberto

Tipo do recurso

Ano de criação

Produção nacional

Revisado por pares

Áreas

Idioma

Editores

Artigo Acesso aberto Revisado por pares

Andrea Bezjak, Dongsheng Tu, Lesley Seymour, Gary M. Clark, Aleksandra Trajković, Mauro Zukin, Joseph Ayoub, S. Lago, Ronaldo de Albuquerque Ribeiro, Alexandra Gerogianni, Arnold Cyjon, Jonathan Noble, Francis Laberge, Raymond Tsz‐Tong Chan, David Fenton, Joachim von Pawel, Martin Reck, Frances A. Shepherd,

Purpose This report describes the quality of life (QOL) findings of a randomized placebo controlled study of erlotinib, an epidermal growth factor receptor inhibitor, in patients with non–small-cell lung cancer (NSCLC). Patients and Methods This double-blind phase III trial randomly assigned 731 patients with NSCLC who had progressed after prior chemotherapy to erlotinib 150 mg daily or placebo, with survival as the primary study outcome. QOL was assessed by European Organisation for Research and ...

Tópico(s): Gastric Cancer Management and Outcomes

2006 - Lippincott Williams & Wilkins | Journal of Clinical Oncology

Errata Acesso aberto Revisado por pares

Stephen Spiro, Lindsay E. James, Robin Rudd, Colin Trask, Jeffrey Tobias, M. Snee, D. Gilligan, Philip I. Murray, M C Ruiz de Elvira, Andrea Bezjak, Dongsheng Tu, Lesley Seymour, Gary M. Clark, Aleksandra Trajković, Mauro Zukin, Joseph Ayoub, S. Lago, Ronaldo De, Albuquerque Ribeiro, Alexandra Gerogianni, Arnold Cyjon, Jonathan Noble, Francis Laberge, T. A. Chan, David Fenton, Daniel G. Haller, Torunn I. Yock, Mark Krailo, Christopher Fryer, Sarah Donaldson, James S. Miser, Zhengjia Chen, Jan C. Buckner, Karla V. Ballman, John C. Michalak, Gary V. Burton, Terrence L. Cascino, Paula J. Schomberg, Sandra J. Strauss, F. Morschhauser, Jürgen Rech, Roland Repp,

contained errors.In Figure 2, inaccurate data were reported.The corrected figure is reprinted below in its entirety.In Figure 3, the legend should have read: "Pharmacokinetics of ADI-SS PEG 20,000 mw in (A) and (C) US patients and (B) and (D) Italian patients with melanoma.The amount of arginine deiminase (ADI) enzyme activity in plasma (A) and (B) and the amount of ADI protein present (C) and (D) were determined.The data shown represent the means Ϯ SE of each of the cohorts."The online version has been corrected ...

2006 - Lippincott Williams & Wilkins | Journal of Clinical Oncology